Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The decision to add acid-suppressing therapy should be individualized based on symptom severity and patient response to initial management strategies
Staying Safe While Saving Money Safety protocols become critical when pursuing cost-reduction strategies for GLP-1 medications
Contraindications Do Not Use If You Have a personal or family history of medullary thyroid carcinoma (MTC) Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Have had a serious hypersensitivity reaction to tirzepatide or any component of the formulation Are pregnant, planning to become pregnant, or breastfeeding Warnings and Precautions Acute pancreatitis: Has been reported in clinical trials
Once-weekly dosing: Tirzepatide is administered once a week by subcutaneous injection, which offers convenience and may improve treatment adherence
Still, the broader trend toward earlier initiation reflects a larger paradigm shift in diabetes care, where patients increasingly benefit from the use of GLP-1s early in their treatment journey
These areas tend to have more subcutaneous fat, which can reduce discomfort
